Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Esperion Therapeutics

Esperion Therapeutics reported $900K in Interest Income for its fiscal quarter ending in March of 2023.

Interest Income Change
Alnylam Pharmaceuticals ALNY:US USD 18.65M 4.58M
Biogen BIIB:US USD 80.9M 31M
BioMarin Pharmaceutical BMRN:US USD 11.94M 3.23M
Cytokinetics CYTK:US USD 6.42M 506K
Eli Lilly LLY:US USD 34.2M 8.7M
Esperion Therapeutics ESPR:US USD 900K 0
Geron GERN:US USD 3.85M 2.62M
Intra Cellular Therapies ITCI:US USD 4.35M 963K
Moderna Inc MRNA:US USD 109M 22M
Nektar Therapeutics NKTR:US USD 4.03M 908K
Pfizer PFE:US USD 177M 40M
Puma Biotechnology PBYI:US USD 537K 18K
Sarepta Therapeutics SRPT:US USD 9.28M 150K
United Therapeutics UTHR:US USD 29.2M 8.4M